US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

KALA

KALA BIO (KALA)

KALA BIO Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KALA

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
29/03/2024	07:00	GlobeNewswire Inc.	KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
04/03/2024	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KALA	KALA BIO Inc
26/02/2024	07:00	GlobeNewswire Inc.	KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	NASDAQ:KALA	KALA BIO Inc
14/02/2024	12:09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:KALA	KALA BIO Inc
06/02/2024	07:00	GlobeNewswire Inc.	KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:KALA	KALA BIO Inc
19/01/2024	15:01	GlobeNewswire Inc.	KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
05/01/2024	15:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KALA	KALA BIO Inc
13/11/2023	07:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KALA	KALA BIO Inc
13/11/2023	07:00	GlobeNewswire Inc.	KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
18/10/2023	15:04	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:KALA	KALA BIO Inc
05/09/2023	07:00	GlobeNewswire Inc.	KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:KALA	KALA BIO Inc
04/08/2023	07:00	GlobeNewswire Inc.	KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
02/08/2023	15:01	GlobeNewswire Inc.	KALA BIO to Participate in Upcoming Investor Conferences in August	NASDAQ:KALA	KALA BIO Inc
02/08/2023	07:00	GlobeNewswire Inc.	Kala Pharmaceuticals Announces Name Change to KALA BIO	NASDAQ:KALA	KALA BIO Inc
19/07/2023	15:01	GlobeNewswire Inc.	Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:KALA	KALA BIO Inc
23/06/2023	15:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KALA	KALA BIO Inc
22/06/2023	15:48	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:KALA	KALA BIO Inc
15/06/2023	10:58	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:KALA	KALA BIO Inc
02/06/2023	07:00	GlobeNewswire Inc.	Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference	NASDAQ:KALA	KALA BIO Inc
31/05/2023	15:03	Edgar (US Regulatory)	Amended Tender Offer Statement by Issuer (sc To-i/a)	NASDAQ:KALA	KALA BIO Inc
11/05/2023	16:26	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:KALA	KALA BIO Inc
09/05/2023	07:00	GlobeNewswire Inc.	Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:KALA	KALA BIO Inc
28/04/2023	07:00	GlobeNewswire Inc.	Combangio, Inc., a Wholly Owned Subsidiary of Kala Pharmaceuticals, Awarded $15 Million by California Institute for Regenerative Medicine to Support Ongoing KPI-012 Program for the Treatment of PCED	NASDAQ:KALA	KALA BIO Inc
12/04/2023	07:00	GlobeNewswire Inc.	Kala Pharmaceuticals Receives FDA Fast Track Designation for KPI-012, a Human MSC-S Therapy for Persistent Corneal Epithelial Defect	NASDAQ:KALA	KALA BIO Inc
29/03/2023	07:00	GlobeNewswire Inc.	Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor	NASDAQ:KALA	KALA BIO Inc
27/03/2023	07:00	GlobeNewswire Inc.	Kala Pharmaceuticals Announces Positive Safety Update from Cohort 1 of CHASE Phase 2b Clinical Trial Evaluating KPI-012 in Patients with PCED	NASDAQ:KALA	KALA BIO Inc
15/03/2023	05:43	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:KALA	KALA BIO Inc
08/03/2023	15:01	GlobeNewswire Inc.	Kala Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference	NASDAQ:KALA	KALA BIO Inc
03/03/2023	15:13	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:KALA	KALA BIO Inc
03/03/2023	07:17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:KALA	KALA BIO Inc

Showing the most relevant articles for your search:NASDAQ:KALA

1 2 3 4 5 6 Próxima >

Financial Select Sector

Bank of America

Health Care Select Sector

Deutsche Telekom (QX)

US Dollar vs MXN

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones